<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:g-custom="http://base.google.com/cns/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>iqur-site</title>
    <link>https://www.iqur.com</link>
    <description />
    <atom:link href="https://www.iqur.com/feed/rss2" type="application/rss+xml" rel="self" />
    <item>
      <title>iQur Researchers Have Genetically Modified the Hepatitis Virus to Treat Flu</title>
      <link>https://www.iqur.com/news/iqur-researchers-have-genetically-modified-hepatitis-virus-treat-flu</link>
      <description>According to a recent issue of Vaccine (1), a team of UK based researchers have genetically modified the Hepatitis B virus shell to contain inserts from influenza virus. The resulting "virus-like particle" is not a live virus, but a completely safe and inert product which can be used as a new universal vaccine against influenza infection.</description>
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           According to a recent issue of Vaccine (1), a team of UK based researchers have genetically modified the Hepatitis B virus shell to contain inserts from influenza virus. The resulting "virus-like particle" is not a live virus, but a completely safe and inert product which can be used as a new universal vaccine against influenza infection.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="http://www.sbwire.com/press-releases/uk-based-researchers-have-genetically-modified-the-hepatitis-virus-to-treat-flu-960830.htm" target="_blank"&gt;&#xD;
      
           Read more
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-612638916.jpg" length="330965" type="image/jpeg" />
      <pubDate>Mon, 09 Apr 2018 16:21:13 GMT</pubDate>
      <guid>https://www.iqur.com/news/iqur-researchers-have-genetically-modified-hepatitis-virus-treat-flu</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-612638916.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-612638916.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>iQur is closing in on a universal flu vaccine</title>
      <link>https://www.iqur.com/news/iqur-closing-universal-flu-vaccine</link>
      <description>Unreliable yearly flu jabs could be a thing of the past as researchers close in on technology that will take down the deadly virus once and for all.</description>
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           iQur, a UK biotechnology company, announced that it has been granted €5 million ($6.6 million) by the European Union Framework 7 fund to develop a universal influenza vaccine based on its proprietary tandem core technology.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.biopharminternational.com/view/iqur-leads-major-european-project-develop-universal-influenza-virus-vaccine" target="_blank"&gt;&#xD;
      
           Read more
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-627196908.jpg" length="193281" type="image/jpeg" />
      <pubDate>Thu, 29 Jun 2017 16:21:13 GMT</pubDate>
      <guid>https://www.iqur.com/news/iqur-closing-universal-flu-vaccine</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-627196908.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-627196908.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>iQur Leads Major European Project to Develop a Universal Influenza Virus Vaccine</title>
      <link>https://www.iqur.com/news/iqur-leads-major-european-project-develop-universal-influenza-virus-vaccine</link>
      <description>iQur announced that it has been granted €5 million ($6.6 million) by the European Union Framework 7 fund.</description>
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;p&gt;&#xD;
      
                      
    Write about something you know. If you don’t know much about a specific topic that will interest your readers, invite an expert to write about it.
  
                    &#xD;
    &lt;/p&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div&gt;&#xD;
  &lt;img src="https://irt-cdn.multiscreensite.com/md/unsplash/dms3rep/multi/desktop/photo-1455849318743-b2233052fcff.jpg" alt="" title=""/&gt;&#xD;
  &lt;span&gt;&#xD;
  &lt;/span&gt;&#xD;
&lt;/div&gt;&#xD;
&lt;div data-rss-type="text"&gt;&#xD;
  &lt;div&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
    Speak to your audience
  
                    &#xD;
    &lt;/b&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;p&gt;&#xD;
      
                      
    You know your audience better than anyone else, so keep them in mind as you write your blog posts. Write about things they care about. If you have a company Facebook page, look here to find topics to write about
  
                    &#xD;
    &lt;/p&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
    Take a few moments to plan your post
  
                    &#xD;
    &lt;/b&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;p&gt;&#xD;
      
                      
    Once you have a great idea for a post, write the first draft. Some people like to start with the title and then work on the paragraphs. Other people like to start with subtitles and go from there. Choose the method that works for you.
  
                    &#xD;
    &lt;/p&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
    Don’t forget to add images
  
                    &#xD;
    &lt;/b&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;p&gt;&#xD;
      
                      
    Be sure to include a few high-quality images in your blog. Images break up the text and make it more readable. They can also convey emotions or ideas that are hard to put into words.
  
                    &#xD;
    &lt;/p&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;b&gt;&#xD;
      
                      
    Edit carefully before posting
  
                    &#xD;
    &lt;/b&gt;&#xD;
    &lt;br/&gt;&#xD;
    &lt;p&gt;&#xD;
      
                      
    Once you’re happy with the text, put it aside for a day or two, and then re-read it. You’ll probably find a few things you want to add, and a couple more that you want to remove. Have a friend or colleague look it over to make sure there are no mistakes. When your post is error-free, set it up in your blog and publish.
  
                    &#xD;
    &lt;/p&gt;&#xD;
  &lt;/div&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-958942902.jpg" length="128753" type="image/jpeg" />
      <pubDate>Tue, 06 Aug 2013 16:21:13 GMT</pubDate>
      <guid>https://www.iqur.com/news/iqur-leads-major-european-project-develop-universal-influenza-virus-vaccine</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-958942902.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-958942902.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
    <item>
      <title>iQur Ltd Closes £2.6 Million Investment, Wins Major DoH Award For Healthcare Innovation &amp; Signs Pipeline Agreement On Anti-Fibrosis IP</title>
      <link>https://www.iqur.com/news/iqur-ltd-closes-ps26-million-investment-wins-major-doh-award-healthcare-innovation-signs</link>
      <description>Advances announced today by the UK-based Company iQur, reinforce its position as a world leader in the development of new treatments for liver disease.</description>
      <content:encoded>&lt;div data-rss-type="text"&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;span&gt;&#xD;
      
           Advances announced today by the UK-based Company iQur, reinforce its position as a world leader in the development of new treatments for liver disease. It has been chosen as the 2005 winner of the Medical Futures Department of Health Award for Best National Healthcare Innovation for its Hepatitis C genotyping service, that can revolutionise the cost effectiveness of treatment for Hepatitis C. Previously trading as HepCgen, iQur also announced today the final close of an oversubscribed GBP2.6 million follow-on financing, as well as the signing of a major licensing deal with the University of Southampton for its patent estate in the treatment of liver fibrosis.
          &#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;br/&gt;&#xD;
  &lt;/p&gt;&#xD;
  &lt;p&gt;&#xD;
    &lt;a href="https://www.biospace.com/article/releases/iqur-ltd-closes-%C3%A3-%C3%A2-2-6-million-investment-wins-major-doh-award-for-healthcare-innovation-and-signs-pipeline-agreement-on-anti-fibrosis-ip-/" target="_blank"&gt;&#xD;
      
           Read more
          &#xD;
    &lt;/a&gt;&#xD;
    &lt;span&gt;&#xD;
      &lt;br/&gt;&#xD;
    &lt;/span&gt;&#xD;
  &lt;/p&gt;&#xD;
&lt;/div&gt;</content:encoded>
      <enclosure url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-522867260.jpg" length="155708" type="image/jpeg" />
      <pubDate>Wed, 09 Nov 2005 10:13:40 GMT</pubDate>
      <guid>https://www.iqur.com/news/iqur-ltd-closes-ps26-million-investment-wins-major-doh-award-healthcare-innovation-signs</guid>
      <g-custom:tags type="string" />
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-522867260.jpg">
        <media:description>thumbnail</media:description>
      </media:content>
      <media:content medium="image" url="https://irp.cdn-website.com/2fd9e9c8/dms3rep/multi/iStock-522867260.jpg">
        <media:description>main image</media:description>
      </media:content>
    </item>
  </channel>
</rss>
